DISEASE-ACTIVITY AND JOINT DAMAGE PROGRESSION IN EARLY RHEUMATOID-ARTHRITIS - RELATION TO IGG, IGA, AND IGM RHEUMATOID-FACTOR

被引:66
作者
EBERHARDT, KB
TRUEDSSON, L
PETTERSSON, H
SVENSSON, B
STIGSSON, L
EBERHARDT, JL
WOLLHEIM, FA
机构
[1] UNIV LUND HOSP,DEPT MED MICROBIOL,S-22185 LUND,SWEDEN
[2] UNIV LUND HOSP,DEPT DIAGNOST RADIOL,S-22185 LUND,SWEDEN
[3] UNIV LUND HOSP,INST OCCUPAT & ENVIRONM MED,S-22185 LUND,SWEDEN
[4] HELSINGBORG GEN HOSP,RHEUMATOL UNIT,HELSINGBORE,SWEDEN
[5] HELSINGBORG GEN HOSP,DEPT DIAGNOST RADIOL,HELSINGBORG,SWEDEN
关键词
D O I
10.1136/ard.49.11.906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical and biochemical correlations with joint damage progression over two years in a consecutive group of 68 patients with rheumatoid arthritis with disease duration of less than two years are reported. Joint damage was assessed with Larsen's severity scale and a measure of change in progression rate constructed. Initial haemoglobin concentration, Ritchie index, and Waaler-Rose titre in combination accounted for one third of the variance in joint damage progression. Rheumatoid factor (RF) concentrations were followed with enzyme linked immunosorbent assays (ELISAs) for IgG RF, IgA RF, and IgM RF. The RF concentrations, except IgG RF, decreased with time; significant correlations between RFs and disease activity were few and barely clinically useful. After two years IgG RF correlated significantly with a radiological score if early non-erosive changes were omitted. All RFs tended to correlate better with this radiological score at all three observation points. Analyses of the change in progression rate indicated a time delay between development of radiographic changes and increase of IgG RF. These results suggest an indirect relation between RFs and joint damage. Clinical and biochemical improvements in early RA occur despite joint damage progression, and conventional markers have insufficient predictive value.
引用
收藏
页码:906 / 909
页数:4
相关论文
共 50 条
  • [41] INVITRO IGM AND IGM RHEUMATOID-FACTOR PRODUCTION AND RESPONSE TO REMITTIVE AGENTS IN RHEUMATOID-ARTHRITIS
    ALARCON, GS
    KOOPMAN, WJ
    SCHROHENLOHER, RE
    ARTHRITIS AND RHEUMATISM, 1985, 28 (03): : 356 - 357
  • [42] OUTCOME OF RHEUMATOID-ARTHRITIS IN RELATION TO AGE AND RHEUMATOID-FACTOR AT DIAGNOSIS
    VANSCHAARDENBURG, D
    HAZES, JMW
    DEBOER, A
    ZWINDERMAN, AH
    MEIJERS, KAE
    BREEDVELD, FC
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (01) : 45 - 52
  • [43] IGM, IGA AND IGG RHEUMATOID FACTORS IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND NORMAL DONORS
    SILVESTRIS, F
    GOODWIN, JS
    WILLIAMS, RC
    CLINICAL RHEUMATOLOGY, 1985, 4 (04) : 392 - 398
  • [44] IMIPRAMINE, RHEUMATOID-ARTHRITIS AND RHEUMATOID-FACTOR
    FOWLER, PD
    MACNEILL, A
    SPENCER, D
    ROBINSON, ET
    DICK, WC
    CURRENT MEDICAL RESEARCH AND OPINION, 1977, 5 (03) : 241 - 246
  • [45] THE ROLE OF RHEUMATOID-FACTOR IN RHEUMATOID-ARTHRITIS
    LARSEN, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1989, 18 (03) : 179 - 179
  • [46] ASSESSING DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS
    SCOTT, DL
    PANAYI, GS
    VANRIEL, PLCM
    SMOLEN, J
    VANDEPUTTE, LBA
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S202 - S202
  • [47] ESTIMATING DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS
    ANDERSON, G
    BOMBARDIER, C
    MEDICAL DECISION MAKING, 1984, 4 (04) : 469 - 487
  • [48] SUPPRESSION OF RHEUMATOID-FACTOR PRODUCTION BY METHOTREXATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS - EVIDENCE FOR DIFFERENTIAL INFLUENCES OF THERAPY AND CLINICAL STATUS ON IGM AND IGA RHEUMATOID-FACTOR EXPRESSION
    ALARCON, GS
    SCHROHENLOHER, RE
    BARTOLUCCI, AA
    WARD, JR
    WILLIAMS, HJ
    KOOPMAN, WJ
    ARTHRITIS AND RHEUMATISM, 1990, 33 (08): : 1156 - 1161
  • [49] AN INDEX OF DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS
    JONES, PW
    ZIADE, MFM
    DAVIS, MJ
    DAWES, PT
    STATISTICS IN MEDICINE, 1993, 12 (12) : 1171 - 1181
  • [50] EVALUATION OF DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS
    GULLBERG, R
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1981, : 31 - 34